Diseases of the cornea are a major cause of blindness worldwide.\[[@ref1]\] The etiology of corneal blindness encompasses a wide variety of inflammatory and infectious eye diseases that ultimately cause functional blindness.[@ref1][@ref2]\] Keratitis is a type of corneal inflammation resulting in vision loss. It typically arises due to noninfectious causes such as eye trauma but can manifest as a result of microbial infection by pathogens such as fungi, bacteria, viruses or amebae.\[[@ref3]\] Until now, infectious keratitis remains one of the main causes of corneal blindness and poses a diagnostic dilemma due to its varied presentation and visual morbidity.\[[@ref1][@ref4]\]

Currently, bacterial keratitis and fungal keratitis are the most common corneal infectious diseases posing a risk to patient vision.\[[@ref5][@ref6]\] The major causative pathogens for bacterial keratitis are *Staphylococcus aureus* and *Pseudomonas aeruginosa*.\[[@ref7]\] Bacterial keratitis frequently leads to severe visual impairment from corneal ulceration, perforation, and scarring.\[[@ref8]\] Following an infection, topical antimicrobial therapy is crucial for managing symptoms.[@ref9][@ref10]\] Risk factors of fungal keratitis include ocular trauma, topical steroid use, ocular surface disease, and contact lens use.\[[@ref11]\] *Aspergillus* spp., *Fusarium* spp., *Candida* spp., are the major causative pathogens of fungal keratitis among many.\[[@ref12]\] Fungal keratitis commonly leads to poor visual acuity,\[[@ref13]\] and is typically managed by polyenes and azoles.\[[@ref14]\]

Each case of infectious keratitis must be confirmed by evaluating corneal infiltrate cultures.\[[@ref15][@ref16]\] Clinically, corneal ulcers are often treated empirically without the use of microbiological analysis due to urgent requests for treatment to achieve optimal therapeutic outcomes.\[[@ref16]\] In order to rely on empirical treatment, the clinician must distinguish between infectious agents based on clinical history, symptoms and characteristics. This method remains highly subjective and risky as incorrect identification of the pathogen facilitates further development of the corneal infection, ultimately leading to a worsened therapeutic outcome. Hence, it is necessary to identify and develop novel approaches to quickly recognize or identify bacterial versus fungal keratitis.

For the specific treatment of infectious keratitis, it is important to reveal the functional and molecular aspects of the disease to develop a possible treatment strategy. In recent years, the analysis of differentially expressed genes (DEGs) in disease has attracted a lot of attention, and may be a promising approach to develop more efficient treatments for keratitis. In this study, we aimed to screen the DEGs in bacterial and fungal keratitis by comparing total gene expression levels in infected versus healthy corneal tissues. This strategy will allow for the identification of candidate genes that can be therapeutically targeted to treat keratitis originating from different infectious agents.

Methods {#sec1-2}
=======

Affymetrix microarray data {#sec2-1}
--------------------------

The transcription profile of GSE58291 was downloaded from the Gene Expression Omnibus (GEO; <http://www.ncbi.nlm.nih.gov/geo/),> a public functional genomics data repository that archives and freely distributes high-throughput molecular abundance data at the National Center for Biotechnology Information. In total, 30 corneal tissue samples were acquired. Among them, three samples showed empty expression profile data, numbered as GSM1406007 (fungal infection), GSM1406009 (bacterial infection), and GSM1406015 (normal control). Hence, 27 tissue samples (12 normal corneas, 7 bacteria-infected corneas, and 8 fungi-infected corneas) were reserved for bioinformatic analysis. Detailed information of the 27 samples is listed in [Table 1](#T1){ref-type="table"}. The causative organisms for bacterially infected corneas included *Streptococcus pneumonia* (*n* = 6) and *Pseudomonas. aeruginosa* (*n* = 1). The causative organisms for fungal keratitis were *Fusarium* sp. (*n* = 5), *Aspergillus* sp. (*n* = 2, *A. flavus* and *A. terreus*) and *Lasiodiplodia* sp. (*n* = 1). Platform information was GPL10558 Illumina Human HT-12 V4.0 expression beadchip. Platform annotation information of the chip expression profiles was also downloaded.

###### 

Characteristic information of 27 samples

  Source name    Sample   Comment (sample_title)            Causative organism
  -------------- -------- --------------------------------- ----------------------------
  GSM1406021 1   Cornea   Cornea_bacterial_keratitis_rep8   *Streptococcus pneumoniae*
  GSM1406018 1   Cornea   Cornea_fungal_keratitis_rep9      *Aspergillus terreus*
  GSM1406017 1   Cornea   Cornea_bacterial_keratitis_rep7   *Pseudomonas aeruginosa*
  GSM1406016 1   Cornea   Cornea_fungal_keratitis_rep8      *Fusarium* sp.
  GSM1406013 1   Cornea   Bacterial keratitis rep6          *Streptococcus pneumoniae*
  GSM1406011 1   Cornea   Cornea_bacterial_keratitis_rep5   *Streptococcus pneumoniae*
  GSM1406008 1   Cornea   Cornea_bacterial_keratitis_rep3   *Streptococcus pneumoniae*
  GSM1406006 1   Cornea   Cornea_fungal_keratitis_rep6      *Fusarium* sp.
  GSM1406003 1   Cornea   Cornea_fungal_keratitis_rep5      *Fusarium* sp.
  GSM1406002 1   Cornea   Cornea_fungal_keratitis_rep4      *Fusarium* sp.
  GSM1406001 1   Cornea   Cornea_fungal_keratitis_rep3      *Lasiodiplodia*
  GSM1406000 1   Cornea   Cornea_bacterial_keratitis_rep2   *Streptococcus pneumoniae*
  GSM1405999 1   Cornea   Cornea_fungal_keratitis_rep2      *Aspergillus flavus*
  GSM1405996 1   Cornea   Cornea_fungal_keratitis_rep1      *Fusarium* sp.
  GSM1405994 1   Cornea   Cornea_bacterial_keratitis_rep1   *Streptococcus pneumoniae*
  GSM1405992 1   Cornea   Cornea_normal_rep1                Normal noninfected tissue
  GSM1405993 1   Cornea   Cornea_normal_rep2                Normal noninfected tissue
  GSM1405995 1   Cornea   Cornea_normal_rep3                Normal noninfected tissue
  GSM1405997 1   Cornea   Cornea_normal_rep4                Normal noninfected tissue
  GSM1405998 1   Cornea   Cornea_normal_rep5                Normal noninfected tissue
  GSM1406004 1   Cornea   Cornea_normal_rep6                Normal noninfected tissue
  GSM1406005 1   Cornea   Cornea_normal_rep7                Normal noninfected tissue
  GSM1406010 1   Cornea   Cornea_normal_rep8                Normal noninfected tissue
  GSM1406012 1   Cornea   Cornea_normal_rep9                Normal noninfected tissue
  GSM1406014 1   Cornea   Cornea_normal_rep10               Normal noninfected tissue
  GSM1406019 1   Cornea   Cornea_normal_rep12               Normal noninfected tissue
  GSM1406020 1   Cornea   Cornea_normal_rep13               Normal noninfected tissue

Data preparation and differential gene expression analysis {#sec2-2}
----------------------------------------------------------

The raw expression profile data in text format were mapped to the corresponding gene names using the GPL10558 Illumina HumanHT-12 V4.0 expression beadchip platform. The average expression value was calculated as the single expression value of this gene, when multiple probes matched to the same gene. Then, logarithm to the base 2 (log2) of expression values was calculated to acquire approximately normally distributed gene expression data, which were continuously subjected to median normalization.[@ref17][@ref18]\] According to sample infection types, comparisons were performed in the bacterial infection versus normal control group, as well as in the fungal infection versus normal control group. Here, samples of normal cornea tissues were classified as the normal control group. The limma\[[@ref19]\] package in R was used to screen DEGs by analyzing the gene expression data of corneal tissues from the above three groups. The Bonferroni\'s method\[[@ref20]\] in multi-test package was applied to adjust raw *P* values for false discovery rate (FDR).\[[@ref21]\] FDR \<0.05 and the absolute value of log2FC \>1 were used as cut-off criteria.

Comparisons of gene expression profiles {#sec2-3}
---------------------------------------

Gene expression profiles are species-specific, suggesting that gene expression is significantly altered in diseased tissues.\[[@ref22]\] According to the expression profile of screened DEGs in bacteria versus fungal and normal samples, we extracted the expression value of DEGs in each sample from the downloaded expression value files. Then, the pheatmap package in R was used to generate expression values by biclustering\[[@ref23][@ref24]\] based on Euclidean distance.\[[@ref25]\] The results are shown as a heatmap.

Calculations of co-expression correlation coefficient among DEGs {#sec2-4}
----------------------------------------------------------------

Although there are approximately 25,000 genes in the human genome, only a fraction of these genes are expressed simultaneously in a single cell or specific tissues during a specific developmental stage.\[[@ref26]\] There are many methods to identify whether co-expression exists between two genes, iamong which the most common method is to use Pearson\'s correlation coefficient.\[[@ref27]\] To obtain DEGs with correlations, the CoExpress tool\[[@ref28]\] (<http://www.bioinformatics.lu/CoExpress/>) was used to calculate correlation coefficients among co-expressed DEGs in the bacterial versus normal group or the fungal versus normal group. Finally, gene pairs with the absolute value of correlation coefficients \>0.9 were retained.

Difference between bacterial versus normal DEGs and fungus versus normal DEGs {#sec2-5}
-----------------------------------------------------------------------------

Through comparison of the gene expression profile between bacterial and normal groups, we acquired the screened DEGs, which are referred to as DEGs1. Similarly, through comparison between fungal and normal groups, we acquired more screened DEGs, which are referred to as DEGs2. To compare the differences between DEGs1 and DEGs2, a Venn diagram was used.\[[@ref29]\]

The fusion of co-expression network {#sec2-6}
-----------------------------------

Based on DEGs1 and DEGs2, we acquired two corresponding co-expression networks by gene co-expression network analysis. Then, the DEGs1-based co-expression network was merged with the DEGs2-based co-expression network using the Cytoscape tool \"Advanced network merge\" to obtain a unique network.\[[@ref30]\]

Functional enrichment analysis of DEGs in fusion co-expression network {#sec2-7}
----------------------------------------------------------------------

Currently, there are multiple tools for gene function enrichment analysis, among which DAVID has been widely used.\[[@ref31]\] Using DAVID software, the biological pathways significantly enriched by DEGs in the fusion co-expression network were identified. A *P* value less than 0.05 was used as a screening threshold.

Pathway analysis of DEGs in fusion co-expression network {#sec2-8}
--------------------------------------------------------

Continuously, the pathway annotations and enrichment analysis were completed using KOBAS\[[@ref32]\] based on algorithm of accumulative hypergeometric distribution. A *P* value less than 0.05 was used as a screening threshold.

Results {#sec1-3}
=======

Data preprocessing and DEGs' identification {#sec2-9}
-------------------------------------------

To remove system errors under sequencing, the data were preprocessed. Through data preparation described in the methods section, we obtained the normalized gene expression data. After preprocessing, the medians of expression values in all the samples were relatively linear, suggesting that the expression data were well-normalized \[[Fig. 1](#F1){ref-type="fig"}\]. A total of 451 DEGs were obtained from the comparison between the bacterial and normal groups and 353 DEGs from the comparison between the fungal and normal groups.

![The boxplot of expression profiling at prestandardization (a) and poststandardization (b). Boxes with white, light gray, and dark gray represent normal cornea, bacterial-infected cornea, and fungus-infected cornea samples, respectively. Y-axis represents gene expression value](IJO-68-39-g001){#F1}

We observed that the screened DEGs could significantly distinguish bacteria/fungus-infected from normal corneal samples \[Figs. [2a](#F2){ref-type="fig"} and [b](#F2){ref-type="fig"}\]. These results indicated that significant sample differences existed among screened DEGs between bacteria-infected and normal groups, as well as between fungus-infected and normal groups.

![The heap map of screened DEGs. (a) Heap map of DEGs screened between bacterial-infected and normal groups. (b) Heap map of DEGs screened between fungus-infected and normal groups. Red color represents high expression, while blue color represents low expression. Color changes from blue to red indicate the corresponding expression value change from lower to higher](IJO-68-39-g002){#F2}

Difference between DEGs between bacterial versus normal and fungus versus normal groups {#sec2-10}
---------------------------------------------------------------------------------------

To compare the difference in DEGs in bacterial versus normal and that in fungal versus normal, a Venn diagram was constructed. We observed that the number of overlapped DEGs was 303, which accounted for 67.18% (303/451) among bacterial versus normal DEGs and 85.84% (303/353) among fungal versus normal DEGs, respectively \[[Fig. 3](#F3){ref-type="fig"}\]. There were 148 DEGs specific to bacterial keratitis, such as CD34 (CD34 molecule, *P* = 1.40E-09, low expression), HK2 (hexokinase 2, *P* = 6.79E-07, overexpression), and *TLR4* (toll-like receptor 4, *P* = 2.35E-09, overexpression) and 50 specific DEGs in fungal keratitis, such as ADH7 (alcohol dehydrogenase 7, *P* = 3.85E-04, low expression), ASGR1 (asialoglycoprotein receptor 1, *P* = 5.49E-08, overexpression), and SOD2 (superoxide dismutase 2, *P* = 7.89E-05, overexpression) \[[Table 2](#T2){ref-type="table"}\]. These results suggest that there were a large number of DEGs identified both in bacteria-infected and fungus-infected corneas, exhibiting tremendous similarities in the above two keratopathies. In addition, the same DEG showed homodromous up- or down-regulation in bacteria and fungus-infected cornea samples, also exhibiting complete uniformity in the above two keratopathies.

![Venn diagram of DEG sets between bacterial vs. normal and fungus vs. normal groups](IJO-68-39-g003){#F3}

###### 

DEGs specific in bacterial and fungal keratitis

  Groups                Gene symbol   *P*        logFC        Gene symbol   *P*         logFC
  --------------------- ------------- ---------- ------------ ------------- ----------- ------------
  Bacterial keratitis   CD34          1.40E-09   −3.550401    PFKFB3        3.02E-06    2.1137928
                        OLFML1        5.96E-07   −2.892602    HK2           6.79E-07    2.1140937
                        HTRA1         6.45E-07   −2.624773    SKAP2         1.81E-09    2.1184403
                        RPPH 1        3.17E-05   −2.483578    ERO1L         2.21E-07    2.1187003
                        CTSF          5.41E-10   −2.477922    HLA-B         2.53E-10    2.1210097
                        IRX2          5.82E-09   −2.47353 1   CASP5         2.97E-07    2.1239787
                        JAM3          3.29E-07   −2.459587    ACSL5         1.43E-07    2.1263413
                        ADRB2         8.62E-06   −2.428554    AP1S2         2.54E-08    2.128140 1
                        ISLR          1.57E-07   −2.407548    CMTM6         4.39E-08    2.1737369
                        MFAP4         6.08E-06   −2.397586    ARRB2         2.28E-10    2.1842634
                        CXCL14        3.46E-05   −2.357675    STX11         0.000133    2.2101693
                        THNSL2        1.95E-06   −2.348504    FAM49B        2.40E-07    2.2180724
                        ELF3          0.000778   −2.341577    ZEB2          1.98E-08    2.224024
                        CLDN5         0.00025    −2.299214    KLRB1         2.96E-06    2.2241235
                        PLA2G2A       0.000888   −2.29423 1   CYB5R4        5.12E-08    2.2409857
                        IGFBP2        1.07E-08   −2.289433    RIPK2         2.26E-05    2.2449883
                        CCDC3         1.50E-05   −2.26505 1   ADORA3        2.83E-08    2.245635
                        FAM46B        8.10E-08   −2.262456    TLR4          2.35E-09    2.2484145
                        GLT8D2        4.16E-05   −2.237313    HLA-F         7.22E-08    2.2579246
                        SERPINF1      7.60E-06   −2.232497    RILPL2        8.36E-06    2.259585
                        SCNN1A        1.16E-05   −2.225126    CCL2          0.000469    2.2641285
                        RCAN2         1.85E-07   −2.222192    UPB1          8.46E-07    2.268115
                        PDGFRL        0.000144   −2.217872    LMNB1         2.24E-07    2.2795219
                        SERPINA5      3.09E-08   −2.211005    ARHGAP15      1.36E-10    2.2814229
                        ZNF750        0.000718   −2.207514    PIK3CG        2.45E-10    2.2903533
                        HBZ           4.51E-07   −2.206249    C5AR1         2.28E-09    2.2964389
                        CPXM2         1.60E-05   −2.204688    GAPT          1.00E-07    2.2981819
                        MT1X          1.76E-05   −2.203755    PLIN2         6.08E-06    2.3070316
                        KAZALD1       1.18E-08   −2.203342    GPR65         1.30E-06    2.317418 1
                        F10           1.30E-07   −2.195377    CXCL16        2.30E-09    2.3231413
                        FBLN5         1.72E-05   −2.189242    MPP 1         1.35E-11    2.3255188
                        PHGDH         2.23E-06   −2.180239    ANXA3         9.88E-09    2.3397564
                        EMX2          2.76E-07   −2.178918    SIGLEC10      2.60E-06    2.3605042
                        LAMB2         4.64E-07   −2.171439    OLR1          5.30E-05    2.3724875
                        SOX15         8.35E-05   −2.16497 1   DRAM 1        2.76E-11    2.3752319
                        SVEP1         5.96E-05   −2.148164    LY96          6.33E-08    2.3793451
                        SNORD97       1.30E-05   −2.147336    IL18RAP       3.49E-06    2.4051193
                        AHNAK         6.83E-08   −2.115137    HIF1A         4.07E-08    2.418505
                        PDGFD         0.000363   −2.112166    HNRNPA3P1     1.83E-06    2.4269378
                        TCEAL2        1.22E-07   −2.103969    GNG2          5.36E-08    2.4428582
                        TMEM100       1.40E-08   −2.100933    SIGLEC5       2.75E-07    2.4445636
                        SETBP1        3.40E-07   −2.099829    CYP27A 1      4.13E-07    2.4615939
                        BMP4          1.51E-09   −2.090556    TMEM71        9.94E-10    2.4708218
                        PRODH         3.54E-10   −2.089715    PTGER4        7.66E-08    2.4890422
                        GPRC5C        2.02E-06   −2.085608    LAMC2         3.97E-05    2.5039927
                        EPHX2         2.72E-09   −2.082969    IL10RA        1.32E-1 1   2.5234075
                        WFDC1         1.40E-07   −2.074921    STEAP 1       1.33E-08    2.5253655
                        MOXD1         0.00125    −2.065241    NRP 1         3.61E-09    2.5407649
                        COL8A1        4.38E-06   −2.056859    EVI2A         1.35E-11    2.5469826
                        CYP26A1       0.00309    −2.042533    BID           1.14E-07    2.5633001
                        MGP           1.58E-06   −2.03842     CXCL2         0.00644     2.578593
                        RIPK4         0.00049    −2.01784     CMTM2         1.02E-07    2.5786635
                        TOB1          5.62E-08   −2.012904    EPB41L3       5.06E-08    2.603111
                        COX7A1        1.54E-06   −2.009043    VNN3          4.45E-09    2.6083142
                        LCP2          5.27E-06   2.0062235    GBP1          3.42E-08    2.6092806
                        ZMYND15       1.93E-10   2.0095573    SNX10         7.88E-08    2.6197063
                        MS4A4A        4.93E-08   2.016654 1   S100A12       1.05E-07    2.6254425
                        SLC43A3       1.59E-06   2.0215348    CTSS          1.95E-11    2.6559225
                        BATF          4.95E-08   2.029239     PTPRE         5.31E-11    2.6785904
                        PDE4B         5.10E-06   2.0297734    KRT6C         0.0182      2.6803395
                        IRAK2         0.000354   2.0404054    SLC16A10      1.07E-08    2.7276327
                        GZMA          7.15E-08   2.0425125    MXD1          2.41E-08    2.7510621
                        ANTXR2        2.61E-07   2.0522199    FYB           9.74E-12    2.778599
                        TFPI2         3.09E-06   2.0532942    GCA           1.01E-10    2.7942486
                        PRDM8         1.35E-06   2.0542583    NPL           3.18E-11    2.79455
                        CXCL1         0.000476   2.0544949    PIK3AP1       3.44E-08    2.799228
                        PLSCR1        8.98E-08   2.0548479    HMOX1         2.92E-06    2.8822109
                        NFE2          2.39E-07   2.0548741    LILRB2        1.62E-10    2.8849687
                        TGM3          0.000106   2.0656169    EMR3          7.77E-10    3.0604573
                        BASP1         7.63E-08   2.088951     HLA-DRB1      0.00407     3.2639598
                        PTGS2         0.0041     2.0901709    IL6           0.000243    3.4041672
                        IL4R          1.74E-06   2.101003     IL1A          0.000232    3.5103275
                        RP2           2.04E-08   2.1014075    HLA-DRB5      0.00321     3.6076907
                        PLEKHO2       1.18E-08   2.106695     MS4A7         1.16E-10    3.7087315
  Fungal keratitis      ADH7          0.000385   −2.41104     KLF4          3.21E-09    -2.086789
                        AGR2          0.000124   −2.382602    LY86          4.45E-11    2.2194223
                        AKR1C2        5.87E-09   −2.122723    MATN2         9.05E-05    -2.021565
                        ASGR1         5.49E-08   1.9998781    MYO1G         6.08E-10    2.4582294
                        BST2          1.92E-09   2.2396599    NEK6          2.09E-10    2.0478274
                        C1QTNF1       0.000141   2.0340408    NQO1          3.37E-07    -2.670235
                        CAMP          1.45E-05   2.3958655    PDXK          1.41E-11    2.05441
                        CCL22         1.21E-06   2.077171     PLEKHO1       2.85E-10    2.2511074
                        CD74          2.59E-09   2.4476072    PMEPA 1       1.26E-06    2.1131556
                        COL1A1        4.88E-05   3.0325672    PTPRO         3.88E-10    2.0927626
                        COL22A1       4.45E-07   2.211018     RARRES2       5.15E-06    2.0625649
                        COL5A1        1.81E-07   2.6823189    RASAL3        7.37E-12    2.1098773
                        CTSZ          1.16E-08   2.0937448    S100A7        9.22E-06    3.0074117
                        CXCL10        3.08E-06   2.2824941    S100A7A       0.000117    2.0777797
                        CXCL13        0.000252   2.1880856    SBSN          0.000988    2.4539646
                        DSG1          0.000938   −2.007756    SLAMF9        1.17E-05    2.077392 1
                        FCGR1A        2.39E-12   2.1689304    SOD2          7.89E-05    3.154099
                        GJB6          2.81E-05   −2.088691    SPRR2D        0.0105      2.4678331
                        GPR68         3.20E-07   2.2930453    SPRR2F        0.0135      2.2326478
                        GPX2          5.67E-06   −2.625696    SPRR3         0.0131      2.2941334
                        GZMB          2.67E-05   2.0633337    STEAP3        5.39E-07    2.0188332
                        HBA2          0.000319   2.9052848    TM4SF19       1.57E-06    2.0371738
                        HBB           0.0028     2.7257732    TMEM176A      4.23E-10    2.1360348
                        ISG15         1.83E-07   2.5742654    TNC           2.55E-08    3.1398672
                        ITGB7         8.13E-09   2.0142005    TRPV2         1.54E-09    2.1827889

DEGs: Differentially expressed genes

Calculations of co-expression correlation coefficient among DEGs {#sec2-11}
----------------------------------------------------------------

The number of co-expressed gene pairs was 117 pairs among bacterial versus normal DEGs and 87 pairs among fungal versus normal DEGs, respectively. The co-expression networks were visualized using Cytoscape tool to obtain the corresponding network graphs.

The fusion of co-expression networks {#sec2-12}
------------------------------------

After fusion of bacterial versus normal and fungal versus normal coexpression networks, a novel fusion coexpression network was generated \[[Fig. 4](#F4){ref-type="fig"}\]. This fusion co-expression network included 79 DEG nodes and 190 connecting edges. Among these 79 DEG nodes, 19 were unique to bacterial versus normal DEGs, 5 were unique to fungal versus normal DEGs, and 55 were present in both comparisons.

![The fusion coexpression network merged from bacterial vs. normal and fungus vs. normal coexpression networks. Dark gray and light gray represent bacterial vs. normal DEGs and fungus vs. normal DEGs, respectively. Triangle and inverted triangle represent up- and down-regulation DEGs, respectively. White rhombus represents DEGs identified both in bacterial vs. normal DEGs and fungus vs. normal DEGs](IJO-68-39-g004){#F4}

Function enrichment analysis of DEGs in fusion co-expression networks {#sec2-13}
---------------------------------------------------------------------

Through analysis of DEGs in fusion co-expression networks using DAVID, we searched nine biological pathways in total that were significantly differentially regulated \[[Supplemental Table 1](#T3){ref-type="table"}\]. Among these nine biological pathways, the immune response was the most significant pathway. Notably, the other eight biological pathways were mainly associated with the immune system.

###### 

Biological pathways searched based on DEGs in fusion co-expression network

  Term                                                                                                     Count   *P*
  -------------------------------------------------------------------------------------------------------- ------- ----------
  GO: 0006955\~immune response                                                                             15      2.58E-06
  GO: 0002504\~antigen processing and presentation of peptide or polysaccharide antigen via MHC class II   5       1.58E-05
  GO: 0009611\~response to wounding                                                                        11      1.54E-04
  GO: 0019882\~antigen processing and presentation                                                         5       5.96E-04
  GO: 0006952\~defense response                                                                            10      0.002058
  GO: 0006954\~inflammatory response                                                                       7       0.003948
  GO: 0034097\~response to cytokine stimulus                                                               4       0.005919
  GO: 0050777\~negative regulation of immune response                                                      3       0.005977
  GO: 0055114\~oxidation reduction                                                                         9       0.009274

Pathway analysis of DEGs in fusion co-expression network {#sec2-14}
--------------------------------------------------------

In total, DEGs in fusion co-expression network were involved seven KEGG pathways \[[Supplemental Table 2](#T4){ref-type="table"}\], among which antigen processing and presentation (hsa04612) was the most striking. Specifically, there were five DEGs identified both between the bacterial versus normal groups and the fungal and normal groups, including HLA-DRB3, IFI30, HLA-DPA1, HLA-DMB, and HLA-DMA, involved in antigen processing and presentation pathways. Among them, HLA-DRB3, HLA-DPA1, HLA-DMB, and HLA-DMA were also involved in the immune response.

###### 

KEGG pathways analyzed based on DEGs in fusion co-expression network

             Pathway                                        *P*        FDR
  ---------- ---------------------------------------------- ---------- ----------
  hsa04612   Antigen processing and presentation            0.001309   0.015919
  hsa05332   Graft-versus-host disease                      0.001468   0.014292
  hsa04940   Type I diabetes mellitus                       0.001822   0.014782
  hsa04672   Intestinal immune network for IgA production   0.002844   0.019737
  hsa05320   Autoimmune thyroid disease                     0.003189   0.019373
  hsa00010   Glycolysis/Gluconeogenesis                     0.005056   0.027221
  hsa05416   Viral myocarditis                              0.008085   0.038996

FDR: false discovery rate; *P*: *P*

Discussion {#sec1-4}
==========

In this study, we primarily screened the DEGs in bacterial keratitis and fungal keratitis through analyzing the gene expression profiles of corneal tissues. In total, there were 451 DEGs identified from bacterial keratitis versus normal corneal tissues and 353 DEGs identified from fungal keratitis versus normal corneal tissues. The number of overlapping DEGs between bacterial keratitis and fungal keratitis was 303, which accounted for a larger proportion in corresponding keratitis. In addition, through co-expression network analysis, 117 co-expressed gene pairs were identified in bacterial keratitis DEGs and 87 pairs in fungal keratitis DEGs. After constructing the fusional co-expression network based on bacterial and fungal keratitis co-expression DEGs, nine biological pathways by function enrichment analysis and seven KEGG pathways by KEGG analysis were identified as significant.

Toll-like receptor 4 (*TLR4*) is a crucial pattern recognition molecule that participates in the innate immune response to lipopolysaccharide, a vital component of Gram-negative bacteria.\[[@ref33]\] It is reported that *TLR4* mRNA levels were significantly upregulated in bacterial (*P. aeruginosa*) infected mouse cornea tissue.\[[@ref34]\] In accordance with this study, our data confirmed that *TLR4* levels were significantly increased by approximately 5-fold in human cornea tissues with bacterial keratitis compared to those in cornea tissues from healthy donors.\[[@ref34]\] The deficiency of *TLR4* in mouse could result in increased polymorphonuclear neutrophil infiltration and proinflammatory cytokine production, as well as decreased β-defensin-2 and inducible nitric oxide synthase production in mouse with *P. aeruginosa* infection of the cornea.\[[@ref34]\] Yan *et al*. reported that *TLR4* found in corneal macrophages could regulate *P. aeruginosa* keratitis by signaling through myeloid differentiation factor 88 (MyD88)-dependent and -independent pathways.\[[@ref35]\] In addition, *TLR4* was also reported to regulate fungal keratitis such as *fusarium* keratitis\[[@ref36]\] and *A. fumigatus* keratitis,\[[@ref37]\] although from our analysis, there were no significant differences in *TLR4* expression between corneal tissues infected with a fungal pathogen versus normal tissues. This suggests that *TLR4* is a candidate target gene to distinguish bacterial keratitis from fungal keratitis. A promising strategy for the diagnosis of infectious keratitis may be developed based on *TLR4* expression.

Among the 50 non-overlapping DEGs in fungal keratitis, *SOD2* levels were found to be significantly increased by about 9-fold in human corneal tissues with fungal keratitis compared to those in normal human corneal tissues. It has been previously reported that *SOD2* expression is significantly increased by about 2-fold in mouse corneas with fungal (*Candida albicans*) keratitis compared to that in healthy mouse corneas.\[[@ref38]\] We speculated that the differences in *SOD2* fold-change between mouse and human could be due to species-specific differences and fungal species. Moreover, *SOD2* was a pivotal DEG node in the fusional co-expression network, which was derived from fungus keratitis DEGs, and co-expression is associated with MYOC, KRT6B, and CSF1R. Meanwhile, *SOD2* was identified to participate in responses to wounding and oxidation reduction pathways. Although there is currently no report describing a role for *SOD2* in keratitis, *SOD2* still remains a potential candidate gene to distinguish between bacterial and fungal keratitis due to its specific association with fungal keratitis.

Furthermore, through functional analysis of DEGs in fusion co-expression networks, we identified nine biological pathways such as pro-inflammatory and anti-inflammatory responses, antigen processing and presentation,\[[@ref39]\] and wounding responses.\[[@ref40]\] The majority of the identified pathways are associated with the immune system. Through KEGG analysis of DEGs in fusion co-expression network, we identified seven KEGG pathways, of which antigen processing and presentation\[[@ref39]\] intestinal immune network for IgA production, autoimmune thyroid disease, and viral myocarditis\[[@ref41]\] are more associated with the immune system. This suggests that perturbations in the immune system induced by pathogen exposure in the cornea leads to the malignant advance of infectious keratitis. Based on our findings, we speculate that strategies aimed at controlling inflammation are a compensatory therapy to alleviate the pain experienced by patients with keratitis excepting to eliminate pathogens, which requires further investigation of the identified immune-related DEGs in infectious keratitis.

In this study we identified novel DEGs associated with bacterial or fungal keratitis; however, our study does have limitations. Firstly, we were limited in the clinical materials including verification of our samples. Secondly, due to the limitations of obtaining human tissue samples, the sample size remains small. Future studies will be required to corroborate our findings using larger sample sizes. Finally, the expression levels of the candidate genes may be affected by the nature of the pathogen, the stage of the disease, or the genetic background of the host. Thus, studies with large sample sizes are warranted to validate our findings in the near future.

Conclusion {#sec1-5}
==========

In summary, our work screened 451 DEGs in corneas with bacterial keratitis and 353 DEGs in corneas with fungal keratitis, in which 148 DEGs were found to be specific to bacterial keratitis and 50 DEGs specific in fungal keratitis. *TLR4* was an upregulated gene specific in bacterial keratitis and *SOD2* was an upregulated gene specific to fungal keratitis. Both genes are promising candidate targets to distinguish bacterial and fungal keratitis.
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